Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Simó

Showing results (131-140 of 358) with videos related to

Pageof 36
Sort By:
Biomedicines|December 24, 2021
Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic RetinopathyHugo Ramos, Patricia Bogdanov, David Sabater, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2022
Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2DOlga González-Albarrán, Cristóbal Morales, Manuel Pérez-Maraver, et al.
Acta Diabetologica|October 12, 2012
Can augmentation index substitute aortic pulse wave velocity in the assessment of central arterial stiffness in type 1 diabetes?Gemma Llauradó, Rafael Simó, Maria Villaplana, et al.
Plos One|March 6, 2009
Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control studyAlbert Lecube, Gabriel Sampol, Patricia Lloberes, et al.
Obesity Surgery|December 19, 2009
Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgeryAlbert Lecube, Gabriel Sampol, Patricia Lloberes, et al.
The Lancet. Diabetes & Endocrinology|August 7, 2016
Diabetic macular oedemaGavin S Tan, Ning Cheung, Rafael Simó, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patientsRafael Simó, Mónica Higuera, Marta García-Ramírez, et al.
Investigative Ophthalmology & Visual Science|July 1, 2011
Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeabilityKyle Trudeau, Sumon Roy, Wen Guo, et al.
Current Medicinal Chemistry|June 11, 2013
Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectivesRafael Simó, Sayon Roy, Francine Behar-Cohen, et al.
Surgery|May 23, 2002
V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriersAlbert Lecube, Cristina Hernandez, Josep Oriola, et al.
Pageof 36

Showing results (131-140 of 358) with videos related to

Sort By:
Pageof 36
Biomedicines|December 24, 2021
Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic RetinopathyHugo Ramos, Patricia Bogdanov, David Sabater, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2022
Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2DOlga González-Albarrán, Cristóbal Morales, Manuel Pérez-Maraver, et al.
Acta Diabetologica|October 12, 2012
Can augmentation index substitute aortic pulse wave velocity in the assessment of central arterial stiffness in type 1 diabetes?Gemma Llauradó, Rafael Simó, Maria Villaplana, et al.
Plos One|March 6, 2009
Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control studyAlbert Lecube, Gabriel Sampol, Patricia Lloberes, et al.
Obesity Surgery|December 19, 2009
Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgeryAlbert Lecube, Gabriel Sampol, Patricia Lloberes, et al.
The Lancet. Diabetes & Endocrinology|August 7, 2016
Diabetic macular oedemaGavin S Tan, Ning Cheung, Rafael Simó, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patientsRafael Simó, Mónica Higuera, Marta García-Ramírez, et al.
Investigative Ophthalmology & Visual Science|July 1, 2011
Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeabilityKyle Trudeau, Sumon Roy, Wen Guo, et al.
Current Medicinal Chemistry|June 11, 2013
Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectivesRafael Simó, Sayon Roy, Francine Behar-Cohen, et al.
Surgery|May 23, 2002
V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriersAlbert Lecube, Cristina Hernandez, Josep Oriola, et al.
Pageof 36